InMed Pharmaceuticals
5 hedge funds and large institutions have $13.3K invested in InMed Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SS
1
SBI Securities
Tokyo,
Japan
|
$621 |
Top Sellers
| 1 |
AI
1
AdvisorShares Investments
Bethesda,
Maryland
|
$0 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$12.6K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $12.6K | 6,106 | -4,302 | -41% |
|
|
SS
2
SBI Securities
Tokyo,
Japan
| $621 | 300 | +300 | New |
|
|
FDCDDQ
3
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $2 | 1 | – | – |
|
|
AWM
4
AllSquare Wealth Management
Albany,
New York
| $2 | 1 | – | – |
|
|
AI
5
AdvisorShares Investments
Bethesda,
Maryland
| – | – | -38,460 | Closed |
|
|
CFGS
6
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
BCV
7
Banque Cantonale Vaudoise
Lausanne,
Switzerland
| $0 | 6 | +6 | New |
|